Related references
Note: Only part of the references are listed.Cancer-causing BRCA2 missense mutations disrupt an intracellular protein assembly mechanism to disable genome maintenance
Miyoung Lee et al.
NUCLEIC ACIDS RESEARCH (2021)
Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules
Judit Jimenez-Sainz et al.
GENES (2021)
Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links
Kimberly A. Rickman et al.
GENES & DEVELOPMENT (2020)
High-throughput functional evaluation of BRCA2 variants of unknown significance
Masachika Ikegami et al.
NATURE COMMUNICATIONS (2020)
XRCC1 promotes replication restart, nascent fork degradation and mutagenic DNA repair in BRCA2-deficient cells
Bradley J. Eckelmann et al.
NAR CANCER (2020)
Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models
Steven N. Hart et al.
GENETICS IN MEDICINE (2019)
High-throughput Evaluation of Protein Migration and Localization after Laser Micro-Irradiation
Sebastian Oeck et al.
SCIENTIFIC REPORTS (2019)
Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches
Lucia Guidugli et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Restoration of Replication Fork Stability in BRCA1-and BRCA2-Deficient Cells by Inactivation of SNF2-Family Fork Remodelers
Angelo Taglialatela et al.
MOLECULAR CELL (2017)
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
Kara N. Maxwell et al.
NATURE COMMUNICATIONS (2017)
Replication fork reversal triggers fork degradation in BRCA2-defective cells
Sofija Mijic et al.
NATURE COMMUNICATIONS (2017)
Germline missense pathogenic variants in the BRCA1 BRCT domain, p.Gly1706Glu and p.Ala1708Glu, increase cellular sensitivity to PARP inhibitor olaparib by a dominant negative effect
Tereza Vaclova et al.
HUMAN MOLECULAR GENETICS (2016)
Distinct binding of BRCA2 BRC repeats to RAD51 generates differential DNA damage sensitivity
Gouri Chatterjee et al.
NUCLEIC ACIDS RESEARCH (2016)
DNA damage foci: Meaning and significance
Kai Rothkamm et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2015)
Promotion of BRCA2-Dependent Homologous Recombination by DSS1 via RPA Targeting and DNA Mimicry
Weixing Zhao et al.
MOLECULAR CELL (2015)
Functional Assays for Analysis of Variants of Uncertain Significance in BRCA2
Lucia Guidugli et al.
HUMAN MUTATION (2014)
An Efficient Pipeline for the Generation and Functional Analysis of Human BRCA2 Variants of Uncertain Significance
Giel Hendriks et al.
HUMAN MUTATION (2014)
BRCA2 diffuses as oligomeric clusters with RAD51 and changes mobility after DNA damage in live cells
Marcel Reuter et al.
JOURNAL OF CELL BIOLOGY (2014)
Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2, and RAD51C Status
J. M. Cunningham et al.
SCIENTIFIC REPORTS (2014)
Endogenous levels of Rad51 and Brca2 are required for homologous recombination and regulated by homeostatic re-balancing
Alissa C. Magwood et al.
DNA REPAIR (2013)
A cancer-associated BRCA2 mutation reveals masked nuclear export signals controlling localization
Anand D. Jeyasekharan et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Micronuclei in genotoxicity assessment: from genetics to epigenetics and beyond
Lidiya Luzhna et al.
Frontiers in Genetics (2013)
Double-Strand Break Repair-Independent Role for BRCA2 in Blocking Stalled Replication Fork Degradation by MRE11
Katharina Schlacher et al.
CELL (2011)
Assessment of Rare BRCA1 and BRCA2 Variants of Unknown Significance Using Hierarchical Modeling
Marinela Capanu et al.
GENETIC EPIDEMIOLOGY (2011)
Purified human BRCA2 stimulates RAD51-mediated recombination
Ryan B. Jensen et al.
NATURE (2010)
Rare, Evolutionarily Unlikely Missense Substitutions in ATM Confer Increased Risk of Breast Cancer
Sean V. Tavtigian et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example
Leila Mohammadi et al.
BMC CANCER (2009)
A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history
Encarna B. Gomez Garcia et al.
BREAST CANCER RESEARCH (2009)
Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2
Sergey G. Kuznetsov et al.
NATURE MEDICINE (2008)
A CRM1-mediated nuclear export signal governs cytoplasmic localization of BRCA2 and is essential for centrosomal localization of BRCA2
X. Han et al.
ONCOGENE (2008)
Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2
Bing Xia et al.
MOLECULAR CELL (2006)
DSS1 is required for the stability of BRCA2
J Li et al.
ONCOGENE (2006)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes
A Willis et al.
ONCOGENE (2004)
DSS1 is required for RAD51 focus formation and genomic stability in mammalian cells
K Gudmundsdottir et al.
EMBO REPORTS (2004)
BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure
HJ Yang et al.
SCIENCE (2002)
Chromosomal instability in BRCA1-or BRCA2-defective human cancer cells detected by spontaneous micronucleus assay
S Ban et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
Variation in cancer risks, by mutation position, in BRCA2 mutation carriers
D Thompson et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
In search of the tumour-suppressor functions of BRCA1 and BRCA2
R Scully et al.
NATURE (2000)
A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals
BR Henderson et al.
EXPERIMENTAL CELL RESEARCH (2000)
Nuclear localization signals of the BRCA2 protein
K Yano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
